Prognostic Value of Lung Injury Biomarkers in Patients Hospitalized With COVID-19 Without Respiratory Failure at Admission

J G Wilson(Stanford University), for the Strategies and Treatments for Respiratory Infections and Viral Emergencies (STRIVE) Network and Therapeutics for Inpatients with COVID-19 (TICO) Trial Study Group(Apple (Israel)), Halima Dawood(Centre for the AIDS Programme of Research in South Africa), Jeremy R. Beitler(Columbia University), Omar Awan(George Washington University), Shweta S. Mistry(University of Minnesota), Birgit Grund(University of Minnesota), Virginia L. Kan(University of South Florida), D Murray(Copenhagen University Hospital), I Kalomenidis(National and Kapodistrian University of Athens), H Cliff Lane(Rigshospitalet), Greg Grandits, Angelika Ringor(University of California, San Francisco), Angela J. Rogers(University of Minnesota), Jamie L. Sturgill(University of Kentucky), Jens D. Lundgren(Rigshospitalet), Minh Q. Ho(University of Central Florida), A Duggal(Cleveland Clinic), A A Ginde(University of Colorado Denver), C Leroux(University of California, San Francisco), W Self(Vanderbilt University Medical Center), S M Brown(University of Utah), Adam Rupert(Frederick National Laboratory for Cancer Research), Kathryn Shaw-Saliba(National Institute of Allergy and Infectious Diseases), Neil R. Aggarwal(University of Colorado Anschutz Medical Campus), Andre C. Kalil(University of Nebraska at Omaha), Michael A. Matthay(University of California, San Francisco), Elizabeth Higgs(National Institute of Allergy and Infectious Diseases), Christina E. Barkauskas(Duke University), Sarah C. Sasson(UNSW Sydney), Hien H. Nguyen(VA Northern California Health Care System)
Critical Care Medicine
May 26, 2026
Cited by 0


Related Papers